Cargando…
Mesenchymal stem cells negatively regulate CD4(+) T cell activation in patients with primary Sjögren syndrome through the miRNA-125b and miRNA-155 TCR pathway
Treatment with mesenchymal stem cells (MSCs) has been revealed to suppress CD4(+) T cells and autoimmunity in both mouse models and patients with primary Sjögren syndrome (pSS); however, the underlying mechanism remains unclear. MicroRNAs (miRNAs or miRs) mediate CD4(+) T cell activation, but the me...
Autores principales: | Gong, Bangdong, Zheng, Ling, Lu, Zhenhao, Huang, Jiashu, Pu, Jincheng, Pan, Shengnan, Zhang, Min, Liu, Jie, Tang, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684863/ https://www.ncbi.nlm.nih.gov/pubmed/33179091 http://dx.doi.org/10.3892/mmr.2020.11681 |
Ejemplares similares
-
Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma
por: He, Jianxia, et al.
Publicado: (2021) -
Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis
patients and their relation to IL-17
por: El-Komy, Mohamed, et al.
Publicado: (2020) -
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
por: Caggiu, Elisa, et al.
Publicado: (2018) -
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
por: Ratnasari, Neneng, et al.
Publicado: (2022) -
Biodistribution and function of extracellular miRNA-155 in mice
por: Bala, Shashi, et al.
Publicado: (2015)